Viewing Study NCT04486651


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-25 @ 9:29 PM
Study NCT ID: NCT04486651
Status: UNKNOWN
Last Update Posted: 2021-01-28
First Post: 2020-07-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer
Sponsor: Taizhou Hanzhong biomedical co. LTD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module